Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease (2013)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1007%2Fs12017-012-8201-2
- Subjects: DOENÇA DE ALZHEIMER; INFLAMAÇÃO; TRANSTORNOS COGNITIVOS; ADIPONECTINA (NÍVEL)
- Language: Inglês
- Imprenta:
- Source:
- Título: Neuromolecular Medicine
- ISSN: 1535-1084
- Volume/Número/Paginação/Ano: v. 15, n. 1, p. 115-121, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TEIXEIRA, Antonio L. et al. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, v. 15, n. 1, p. 115-121, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2. Acesso em: 09 jan. 2026. -
APA
Teixeira, A. L., Diniz, B. S., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., et al. (2013). Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, 15( 1), 115-121. doi:10.1007%2Fs12017-012-8201-2 -
NLM
Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.[citado 2026 jan. 09 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2 -
Vancouver
Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.[citado 2026 jan. 09 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2 - Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
Informações sobre o DOI: 10.1007%2Fs12017-012-8201-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
